Global collaboration with US researchers likely to be set back by years, including on spread of drug-resistant HIV
A flagship programme to create malaria vaccines has been halted by the Trump administration, in just one example of a rippling disruption to health research around the globe since the new US president took power.
The USAid Malaria Vaccine Development Program (MVDP) – which works to prevent child deaths by creating more effective second-generation vaccines – funds research by teams collaborating across institutes, including the US university Johns Hopkins and the UK’s University of Oxford.
About Author
More Stories
Stonehenge-like circle unearthed in Denmark may have links to UK
It’s Jekyll and Hyde, says son of French surgeon accused of abusing 299 patients
More than 200,000 Canadians sign petition to revoke Musk’s citizenship